SEC Form 4 · accession 0001144204-17-022666
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Talamo
Officer — SVP and CFO
Period of report
Apr 25, 2017
Accepted (ET)
Apr 27, 2017 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 25, 2017 | F | 214 | $4.74 | D | 21,601 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 14,003 shares of unvested restricted stock.
Remarks
Senior Vice President and Chief Financial Officer